KREJČÍ, Marta, Michael DOUBEK, Yvona BRYCHTOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Boris TICHÝ, Hana SKUHROVÁ FRANCOVÁ, Milan NAVRÁTIL, Miroslav TOMIŠKA, Ondřej HORKÝ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia. Annals of hematology. New York: Springer Verlag, 2013, vol. 92, No 2, p. 249-254. ISSN 0939-5555. doi:10.1007/s00277-012-1579-y.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia
Authors KREJČÍ, Marta (203 Czech Republic, guarantor, belonging to the institution), Michael DOUBEK (203 Czech Republic, belonging to the institution), Yvona BRYCHTOVÁ (203 Czech Republic, belonging to the institution), Olga STEHLÍKOVÁ (203 Czech Republic), Jana CHOVANCOVÁ (203 Czech Republic), Boris TICHÝ (203 Czech Republic, belonging to the institution), Hana SKUHROVÁ FRANCOVÁ (203 Czech Republic), Milan NAVRÁTIL (203 Czech Republic, belonging to the institution), Miroslav TOMIŠKA (203 Czech Republic, belonging to the institution), Ondřej HORKÝ (203 Czech Republic), Šárka POSPÍŠILOVÁ (203 Czech Republic, belonging to the institution) and Jiří MAYER (203 Czech Republic, belonging to the institution).
Edition Annals of hematology, New York, Springer Verlag, 2013, 0939-5555.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.396
RIV identification code RIV/00216224:14740/13:00065704
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1007/s00277-012-1579-y
UT WoS 000313445100014
Keywords in English chronic lymphocytic leukemia; reduced-intensity conditioning; fludarabine; cytarabine
Tags ok, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Olga Křížová, učo 56639. Changed: 25. 4. 2014 15:50.
Abstract
Allogeneic stem cell transplantation (SCT) is a treatment option for patients with poor-risk chronic lymphocytic leukemia (CLL).Sequential use of chemotherapy and reduced-intensity conditioning has been proposed to improve the treatment outcomes.
Links
ED1.1.00/02.0068, research and development projectName: CEITEC - central european institute of technology
EE2.3.20.0045, research and development projectName: Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny
FR-TI2/254, research and development projectName: *Real-time PCR soupravy pro diagnostiku v onkologii (Acronym: ONKOKITY)
Investor: Ministry of Industry and Trade of the CR
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 18. 5. 2022 23:08